COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study
Introduction Despite the effectiveness of COVID-19 vaccines in preventing severe COVID-19 outcomes, a small percentage of fully vaccinated persons will develop symptomatic or asymptomatic infections with SARS-CoV-2, which is referred to as ‘breakthrough COVID-19’. People living with HIV (PLWH) appea...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/8/e067095.full |
| _version_ | 1797660793920028672 |
|---|---|
| author | Bankole Olatosi Jiajia Zhang Sharon Weissman Xiaoming Li Xueying Yang |
| author_facet | Bankole Olatosi Jiajia Zhang Sharon Weissman Xiaoming Li Xueying Yang |
| author_sort | Bankole Olatosi |
| collection | DOAJ |
| description | Introduction Despite the effectiveness of COVID-19 vaccines in preventing severe COVID-19 outcomes, a small percentage of fully vaccinated persons will develop symptomatic or asymptomatic infections with SARS-CoV-2, which is referred to as ‘breakthrough COVID-19’. People living with HIV (PLWH) appear to have an elevated risk of severe COVID-19 outcomes, yet the effectiveness of the COVID-19 vaccine in this population remains unclear due to the limited research efforts in this population in the real world. This study aims to characterise and compare the breakthrough COVID-19 (eg, prevalence and disease severity) between PLWH and non-PLWH and then examine whether HIV markers play a role in COVID-19 vaccine effectiveness within the PLWH population.Methods and analysis This cohort study will merge electronic health records data from multiple data sources in South Carolina (SC), including the ‘HIV Cohort’ (n=12 203) identified from the statewide Enhanced HIV/AIDS Reporting System, ‘Vaccine Cohort’ from the Statewide Immunisation Online Network which provides patient-level immunisation records (n=~1.71 million), and ‘COVID-19 Cohort’ which includes healthcare encounters and COVID-19 diagnosis information for all individuals who were tested for COVID-19 (n=~3.41 million). The PLWH will be matched with a comparison group of non-PLWH by the propensity score matching method. To distinguish the role of immunity level in affecting the vaccine effectiveness, we will conduct subgroup analyses to compare the outcome of virally controlled and immunosuppressed PLWH with non-PLWH. Conditional logistic regression and generalised linear models will be employed to analyse the relationship between HIV status and protection durability by adjusting for potential confounders.Ethics and dissemination The study was approved by the Institutional Review Board at the University of South Carolina (Pro00117583) as a Non-Human Subject study. The study’s findings will be published in peer-reviewed journals and disseminated at national and international conferences and through social media. |
| first_indexed | 2024-03-11T18:35:04Z |
| format | Article |
| id | doaj.art-8c3f9a231a03462fa04d0294f7bfc0fd |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-03-11T18:35:04Z |
| publishDate | 2022-08-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-8c3f9a231a03462fa04d0294f7bfc0fd2023-10-13T04:40:07ZengBMJ Publishing GroupBMJ Open2044-60552022-08-0112810.1136/bmjopen-2022-067095COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort studyBankole Olatosi0Jiajia Zhang1Sharon Weissman2Xiaoming Li3Xueying Yang4Health Services Policy and Management, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USADepartment of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USADepartment of Infectious Diseases, University of South Carolina, Columbia, South Carolina, USASouth Carolina SmartState Center for Healthcare Quality, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USAHealth Promotion Education and Behavior, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USAIntroduction Despite the effectiveness of COVID-19 vaccines in preventing severe COVID-19 outcomes, a small percentage of fully vaccinated persons will develop symptomatic or asymptomatic infections with SARS-CoV-2, which is referred to as ‘breakthrough COVID-19’. People living with HIV (PLWH) appear to have an elevated risk of severe COVID-19 outcomes, yet the effectiveness of the COVID-19 vaccine in this population remains unclear due to the limited research efforts in this population in the real world. This study aims to characterise and compare the breakthrough COVID-19 (eg, prevalence and disease severity) between PLWH and non-PLWH and then examine whether HIV markers play a role in COVID-19 vaccine effectiveness within the PLWH population.Methods and analysis This cohort study will merge electronic health records data from multiple data sources in South Carolina (SC), including the ‘HIV Cohort’ (n=12 203) identified from the statewide Enhanced HIV/AIDS Reporting System, ‘Vaccine Cohort’ from the Statewide Immunisation Online Network which provides patient-level immunisation records (n=~1.71 million), and ‘COVID-19 Cohort’ which includes healthcare encounters and COVID-19 diagnosis information for all individuals who were tested for COVID-19 (n=~3.41 million). The PLWH will be matched with a comparison group of non-PLWH by the propensity score matching method. To distinguish the role of immunity level in affecting the vaccine effectiveness, we will conduct subgroup analyses to compare the outcome of virally controlled and immunosuppressed PLWH with non-PLWH. Conditional logistic regression and generalised linear models will be employed to analyse the relationship between HIV status and protection durability by adjusting for potential confounders.Ethics and dissemination The study was approved by the Institutional Review Board at the University of South Carolina (Pro00117583) as a Non-Human Subject study. The study’s findings will be published in peer-reviewed journals and disseminated at national and international conferences and through social media.https://bmjopen.bmj.com/content/12/8/e067095.full |
| spellingShingle | Bankole Olatosi Jiajia Zhang Sharon Weissman Xiaoming Li Xueying Yang COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study BMJ Open |
| title | COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study |
| title_full | COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study |
| title_fullStr | COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study |
| title_full_unstemmed | COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study |
| title_short | COVID-19 vaccine effectiveness among people living with and without HIV in South Carolina, USA: protocol of a population-based cohort study |
| title_sort | covid 19 vaccine effectiveness among people living with and without hiv in south carolina usa protocol of a population based cohort study |
| url | https://bmjopen.bmj.com/content/12/8/e067095.full |
| work_keys_str_mv | AT bankoleolatosi covid19vaccineeffectivenessamongpeoplelivingwithandwithouthivinsouthcarolinausaprotocolofapopulationbasedcohortstudy AT jiajiazhang covid19vaccineeffectivenessamongpeoplelivingwithandwithouthivinsouthcarolinausaprotocolofapopulationbasedcohortstudy AT sharonweissman covid19vaccineeffectivenessamongpeoplelivingwithandwithouthivinsouthcarolinausaprotocolofapopulationbasedcohortstudy AT xiaomingli covid19vaccineeffectivenessamongpeoplelivingwithandwithouthivinsouthcarolinausaprotocolofapopulationbasedcohortstudy AT xueyingyang covid19vaccineeffectivenessamongpeoplelivingwithandwithouthivinsouthcarolinausaprotocolofapopulationbasedcohortstudy |